![Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries - The Lancet Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries - The Lancet](https://www.thelancet.com/cms/asset/5512d4aa-3f81-40fa-923d-85d1bf4bb546/gr1.jpg)
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries - The Lancet
![Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series - The Lancet Gastroenterology & Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series - The Lancet Gastroenterology &](https://www.thelancet.com/cms/attachment/710a6acd-62ff-47f7-a70b-de6989ef9638/gr1.jpg)
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series - The Lancet Gastroenterology &
![Neoplasia-associated Chromosome Translocations Resulting in Gene Truncation | Cancer Genomics & Proteomics Neoplasia-associated Chromosome Translocations Resulting in Gene Truncation | Cancer Genomics & Proteomics](https://cgp.iiarjournals.org/sites/default/files/highwire/cgp/19/6.cover-source.jpg)
Neoplasia-associated Chromosome Translocations Resulting in Gene Truncation | Cancer Genomics & Proteomics
![Frontiers | Safrana l Prevents Prostate Cancer Recurrence by Blocking the Re-activation of Quiescent Cancer Cells via Downregulation of S-Phase Kinase-Associated Protein 2 Frontiers | Safrana l Prevents Prostate Cancer Recurrence by Blocking the Re-activation of Quiescent Cancer Cells via Downregulation of S-Phase Kinase-Associated Protein 2](https://www.frontiersin.org/files/Articles/598620/fcell-08-598620-HTML/image_m/fcell-08-598620-g001.jpg)
Frontiers | Safrana l Prevents Prostate Cancer Recurrence by Blocking the Re-activation of Quiescent Cancer Cells via Downregulation of S-Phase Kinase-Associated Protein 2
Skin-Patchable Electrodes for Biosensor Applications: A Review | ACS Biomaterials Science & Engineering
Indian Cricket Team - Second wicket for Navdeep Saini. 🙌🙌 Australia 8 down as Mitchell Starc departs. #TeamIndia #AUSvIND Follow the match 👉 bit.ly/AusvInd3rdTest | Facebook
![Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets](https://www.mdpi.com/cells/cells-07-00176/article_deploy/html/images/cells-07-00176-g001.png)
Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
![Therapeutic Potential of Standardized Extract of Melilotus indicus (L.) All. and Its Phytochemicals against Skin Cancer in Animal Model: In Vitro, In Vivo, and In Silico Studies | ACS Omega Therapeutic Potential of Standardized Extract of Melilotus indicus (L.) All. and Its Phytochemicals against Skin Cancer in Animal Model: In Vitro, In Vivo, and In Silico Studies | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.2c03053/asset/images/large/ao2c03053_0010.jpeg)